Skip to content

A narrative synthesis of research with 5-MeO-DMT.

Anna O Ermakova, Fiona Dunbar, James Rucker, Matthew W Johnson

Journal of psychopharmacology (Oxford, England) March 1, 2022 DOI: 10.1177/02698811211050543 via PubMed

Summary

AI-generated from the abstract

5-MeO-DMT is a short-acting psychedelic tryptamine found in nature and used historically for spiritual purposes. This review of existing literature covers its pharmacology, chemistry, metabolism, epidemiological studies, and reported effects. 5-MeO-DMT acts as a serotonergic agonist with highest affinity for 5-HT1A receptors. Animal model studies exist, but human clinical studies are lacking. Epidemiological data indicate it induces profound alterations in consciousness, including mystical experiences, with potential beneficial long-term effects on mental health and well-being. Its short duration, relative lack of visual effects, and higher rates of ego-dissolution make it a potentially useful addition to the psychedelic pharmacopoeia, warranting further clinical exploration with appropriate precautions.

Study at a glance

Characteristics Review Peer reviewed
Topics 5-MeO-DMT Ego dissolution
Keywords Classic psychedelic Hallucinogen 5-MEO-DMT: 5-MEO-DMT
Citations 83
Key finding 5-MeO-DMT induces profound alterations in consciousness and mystical experiences, with potential beneficial long-term effects on mental health and well-being, but human clinical studies are lacking.

Abstract

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring, short-acting psychedelic tryptamine, produced by a variety of plant and animal species. Plants containing 5-MeO-DMT have been used throughout history for ritual and spiritual purposes. The aim of this article is to review the available literature about 5-MeO-DMT and inform subsequent clinical development. We searched PubMed database for articles about 5-MeO-DMT. Search results were cross-checked against earlier reviews and reference lists were hand searched. Findings were synthesised using a narrative synthesis approach. This review covers the pharmacology, chemistry and metabolism of 5-MeO-DMT, as well epidemiological studies, and reported adverse and beneficial effects. 5-MeO-DMT is serotonergic agonist, with highest affinity for 5-HT1A receptors. It was studied in a variety of animal models, but clinical studies with humans are lacking. Epidemiological studies indicate that, like other psychedelics, 5-MeO-DMT induces profound alterations in consciousness (including mystical experiences), with potential beneficial long-term effects on mental health and well-being. 5-MeO-DMT is a potentially useful addition to the psychedelic pharmacopoeia because of its short duration of action, relative lack of visual effects and putatively higher rates of ego-dissolution and mystical experiences. We conclude that further clinical exploration is warranted, using similar precautions as with other classic psychedelics.

Explore topics

Comments

No comments yet.

Log in to comment